JP2002508745A5 - - Google Patents

Download PDF

Info

Publication number
JP2002508745A5
JP2002508745A5 JP1998543173A JP54317398A JP2002508745A5 JP 2002508745 A5 JP2002508745 A5 JP 2002508745A5 JP 1998543173 A JP1998543173 A JP 1998543173A JP 54317398 A JP54317398 A JP 54317398A JP 2002508745 A5 JP2002508745 A5 JP 2002508745A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998543173A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002508745A (ja
JP4391597B2 (ja
Filing date
Publication date
Priority claimed from US08/982,962 external-priority patent/US6011036A/en
Application filed filed Critical
Priority claimed from PCT/US1998/007285 external-priority patent/WO1998045292A1/en
Publication of JP2002508745A publication Critical patent/JP2002508745A/ja
Publication of JP2002508745A5 publication Critical patent/JP2002508745A5/ja
Application granted granted Critical
Publication of JP4391597B2 publication Critical patent/JP4391597B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP54317398A 1997-12-02 1998-04-10 抗糖尿病性、低脂質性及び抗高血圧性を有するチアゾリンジオンとオキサゾリジンジオン誘導体 Expired - Fee Related JP4391597B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/982,962 US6011036A (en) 1997-04-15 1997-12-02 Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them
US08/982,962 1997-12-02
PCT/US1998/007285 WO1998045292A1 (en) 1997-12-02 1998-04-10 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties

Publications (3)

Publication Number Publication Date
JP2002508745A JP2002508745A (ja) 2002-03-19
JP2002508745A5 true JP2002508745A5 (OSRAM) 2005-11-24
JP4391597B2 JP4391597B2 (ja) 2009-12-24

Family

ID=25529696

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54317398A Expired - Fee Related JP4391597B2 (ja) 1997-12-02 1998-04-10 抗糖尿病性、低脂質性及び抗高血圧性を有するチアゾリンジオンとオキサゾリジンジオン誘導体

Country Status (6)

Country Link
EP (1) EP0971917B1 (OSRAM)
JP (1) JP4391597B2 (OSRAM)
AT (1) ATE212991T1 (OSRAM)
AU (1) AU6966498A (OSRAM)
DE (1) DE69803750T2 (OSRAM)
WO (1) WO1998045292A1 (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921567A1 (de) 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
DE60114996T2 (de) 2000-03-08 2006-08-10 Novo Nordisk A/S Senkung des serum cholesterols
EP2243776A1 (en) 2001-10-12 2010-10-27 High Point Pharmaceuticals, LLC Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
WO2003055482A1 (en) 2001-12-21 2003-07-10 Novo Nordisk A/S Amide derivatives as gk activators
US7196085B2 (en) * 2002-04-30 2007-03-27 Kudos Pharmaceuticals Limited Phthalazinone derivatives
AU2003243921B2 (en) 2002-06-27 2009-05-07 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
MXPA06003474A (es) 2003-09-30 2006-06-05 Novo Nordisk As Agonistas de receptores de melanocortina.
WO2005056036A2 (en) 2003-12-09 2005-06-23 Novo Nordisk A/S Regulation of food preference using glp-1 agonists
PT1723128E (pt) 2004-01-06 2013-02-27 Novo Nordisk As Heteroaril-ureias e o seu uso como activadores da glicoquinase
JP2007536344A (ja) 2004-05-04 2007-12-13 ノボ　ノルディスク　アクティーゼルスカブ 新規のインドール誘導体
EP1758575A1 (en) 2004-06-11 2007-03-07 Novo Nordisk A/S Counteracting drug-induced obesity using glp-1 agonists
CN101060856B (zh) 2004-11-22 2011-01-19 诺和诺德公司 可溶、稳定的含胰岛素制剂
US8148412B2 (en) 2004-12-03 2012-04-03 Novo Nordisk A/S Heteroaromatic glucokinase activators
EP2386554A1 (en) 2005-07-04 2011-11-16 High Point Pharmaceuticals, LLC Compounds active at the histamine H3 receptor
BRPI0612996A2 (pt) 2005-07-14 2010-12-14 Novo Nordisk As ativadores de urÉia glucocinase
US8106090B2 (en) 2005-07-20 2012-01-31 Eli Lilly And Company 1-amino linked compounds
DK1951658T3 (da) 2005-11-17 2012-10-15 Lilly Co Eli Glucagonreceptorantagonister, fremstilling og terapeutiske anvendelser
US8394842B2 (en) 2006-03-28 2013-03-12 High Point Pharmaceuticals, Llc Benzothiazoles having histamine H3 receptor activity
EP2079732B9 (en) 2006-05-29 2012-03-21 High Point Pharmaceuticals, LLC 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
EP2097388B1 (en) 2006-11-15 2011-09-07 High Point Pharmaceuticals, LLC Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
US8022066B2 (en) 2006-11-15 2011-09-20 High Point Pharmaceuticals, Llc 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes
AU2008204530B2 (en) 2007-01-11 2013-08-01 Vtv Therapeutics Llc Urea glucokinase activators
BR112012021231A2 (pt) 2010-02-26 2015-09-08 Basf Plant Science Co Gmbh método para acentuar o rendimento em plantas, planta, construto, uso de um construto, método para a produção de uma planta transgênica, partes coletáveis de uma planta, produtos derivados de uma planta, uso de um ácido nucleíco e método para a produção de um produto
WO2011104378A1 (en) 2010-02-26 2011-09-01 Novo Nordisk A/S Peptides for treatment of obesity
EP2552950A1 (en) 2010-03-26 2013-02-06 Novo Nordisk A/S Novel glucagon analogues
EP2670368A4 (en) 2011-02-03 2015-04-15 Pharmedica Ltd NEW ORAL DISSOLUTION FILMS FOR INSULIN DELIVERY FOR THE TREATMENT OF DIABETES
RU2013145013A (ru) 2011-03-28 2015-05-10 Ново Нордиск А/С Новые аналоги глюкагона
MY167234A (en) 2011-09-23 2018-08-14 Novo Nordisk As Novel glucagon analogues
MY174727A (en) 2013-04-18 2020-05-11 Novo Nordisk As Stable, protracted glp-1/glucagon receptor co-agonists for medical use
US10570184B2 (en) 2014-06-04 2020-02-25 Novo Nordisk A/S GLP-1/glucagon receptor co-agonists for medical use
JP2020514365A (ja) 2017-03-15 2020-05-21 ノヴォ ノルディスク アー／エス メラノコルチン４受容体に結合可能な二環式化合物
WO2019219714A1 (en) 2018-05-15 2019-11-21 Novo Nordisk A/S Compounds capable of binding to melanocortin 4 receptor
WO2020053414A1 (en) 2018-09-14 2020-03-19 Novo Nordisk A/S Bicyclic compounds capable of acting as melanocortin 4 receptor agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
GB9023585D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Similar Documents

Publication Publication Date Title
JP2000507042A5 (OSRAM)
JP2000509942A5 (OSRAM)
JP2000510751A5 (OSRAM)
JP2000509912A5 (OSRAM)
JP2000509635A5 (OSRAM)
JP2000509637A5 (OSRAM)
JP2001514762A5 (OSRAM)
JP2002501458A5 (OSRAM)
JP2001506190A5 (OSRAM)
JP2001527689A5 (OSRAM)
JP2000509587A5 (OSRAM)
JP2000507433A5 (OSRAM)
JP2000508866A5 (OSRAM)
JP2000510793A5 (OSRAM)
JP2002503179A5 (OSRAM)
JP2000508841A5 (OSRAM)
JP2000508680A5 (OSRAM)
JP2002501389A5 (OSRAM)
JP2000509853A5 (OSRAM)
JP2000509755A5 (OSRAM)
JP2000510969A5 (OSRAM)
JP2000510247A5 (OSRAM)
JP2000508102A5 (OSRAM)
JP2000508836A5 (OSRAM)
JP2000509520A5 (OSRAM)